Abstract PS3-02: Induction of Cisplatin/abraxane/pembrolizumab followed by pembrolizumab ± Olaparib Maintenance in triple-negative Metastatic breast cancer patients (COMPLEMENT) – A Randomized, Open-label, Phase II Study
Year: 2025
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Xichun Hu, Chengcheng Gong, Zhonghua Tao, Biyun Wang, Leiping Wang, Jun Cao, Mingchuan Zhao, Jian Zhang, Jian Huang
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4411284842